Seven patients (9.8%) were diagnosed with CNS leukemia (e.g., CNS2 and CNS3), including 3 with T-ALL, 4 with B-ALL, 1 with BCR-ABL+ disease, and 1 with TEL-ABL+ disease. This evidence concerns the gene ABL1 and central nervous system leukemia.